{"id":"NCT01662882","sponsor":"Avid Radiopharmaceuticals","briefTitle":"A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)","officialTitle":"An Open Label, Parallel Group, Multicenter Study, Evaluating the Safety and Imaging Characteristics of Florbetapir (18F) in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2012-10","primaryCompletion":"2013-02","completion":"2013-02","firstPosted":"2012-08-13","resultsPosted":"2013-09-19","lastUpdate":"2013-09-19"},"enrollment":48,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Alzheimer's Disease","Mild Cognitive Impairment"],"interventions":[{"type":"DRUG","name":"florbetapir (18F)","otherNames":["18F-AV-45","Amyvid","Florbetapir F 18"]}],"arms":[{"label":"AD Subjects","type":"EXPERIMENTAL"},{"label":"MCI","type":"EXPERIMENTAL"},{"label":"Healthy Controls","type":"EXPERIMENTAL"}],"summary":"Evaluate florbetapir (18F) positron emission tomography (PET) imaging for distinguishing Japanese healthy control subjects, from Japanese subjects with Alzheimer's disease (AD) or Mild cognitive impairment (MCI).","primaryOutcome":{"measure":"Qualitative Amyloid Image Assessment","timeFrame":"50-60 min after injection","effectByArm":[{"arm":"AD Subjects","deltaMin":12,"sd":null},{"arm":"MCI Subjects","deltaMin":5,"sd":null},{"arm":"Healthy Controls","deltaMin":3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0253"},{"comp":"OG000 vs OG002","p":"0.0004"},{"comp":"OG001 vs OG002","p":"0.4184"},{"comp":"OG000 vs OG001 vs OG002","p":"0.0008"}]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":2,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":15},"commonTop":["Blood pressure increased","Fatigue","Malaise","Vessel puncture site pain","Vision blurred"]}}